Ibrance (palbociclib) : Uses, 2-negative (HR-positive, HER2- negative), CDK4 and CDK6
u
Ibrance is the brand name for palbociclib, a drug utilized in the therapy of particular sorts of bosom disease. In particular, it is endorsed for use in blend with different medications to treat chemical receptor-positive, human epidermal development factor receptor 2-negative (HR-positive, HER2-negative) high level or metastatic bosom malignant growth in postmenopausal ladies.
Palbociclib is a kind of designated treatment that works by restraining specific proteins (CDK4 and CDK6) engaged with the cell cycle, subsequently dialing back the development of disease cells. It is typically endorsed in mix with hormonal treatments like aromatase inhibitors.
Follow your doctor's instructions and talk to them about any questions or concerns you may have about Ibrance, as with any medication. They are able to provide you with information that is more tailored to your particular medical condition.
